Literature DB >> 33981360

Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer.

Bo Lin1,2,3, Shunji Wang1,2,3, Youdan Yao1,2,3, Yuehong Shen1,2,3, Hongyu Yang1,2,3.   

Abstract

The occurrence and prognosis of head and neck squamous cell cancer (HNSC) is closely associated with human papillomavirus (HPV) infection. Transmembrane channel-like 8 (TMC8) is a key gene affecting the susceptibility of HPV and that plays an important role in T cell regulation. However, the mechanism by which TMC8 affects T cells and whether it further affects the prognosis of patients with HNSC remains unclear. In the present study, oral cancer cell lines and independent tumor specimens were used to detect TMC8 expression in HNSC. Differential expression of TMC8, methylation status, function and associated signaling pathways were further analyzed. Then, multiple databases were cross-analyzed for the relationship of TMC8 with immune cell infiltration and its impact on the prognosis of numerous types of cancer. The results showed that TMC8 was upregulated in HNSC and high expression was predictive of an improved prognosis. Furthermore, TMC8 was concentrated in multiple immune-associated signaling pathways and the expression of TMC8 was associated with the infiltration of CD4+ T cells and their subsets, including CD8+ T cells, B cells and macrophages, suggesting that TMC8 may play an anti-HPV role by regulating CD4+ T cells. Thus, TMC8 plays an anti-HPV role by regulating the infiltration level of CD4+ T cells, and could therefore be used as a potential prognostic marker for patients with HNSC. Copyright: © Lin et al.

Entities:  

Keywords:  expression; head and neck squamous cancer; immune; prognosis; transmembrane channel-like 8

Year:  2021        PMID: 33981360      PMCID: PMC8108259          DOI: 10.3892/ol.2021.12759

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  3 in total

1.  General Features and Novel Gene Signatures That Identify Epstein-Barr Virus-Associated Epithelial Cancers.

Authors:  Chukkris Heawchaiyaphum; Chamsai Pientong; Hironori Yoshiyama; Hisashi Iizasa; Watcharapong Panthong; Tipaya Ekalaksananan
Journal:  Cancers (Basel)       Date:  2021-12-22       Impact factor: 6.639

2.  TMC5 is Highly Expressed in Human Cancers and Corelates to Prognosis and Immune Cell Infiltration: A Comprehensive Bioinformatics Analysis.

Authors:  Hui Zhang; Xu Zhang; Weiguo Xu; Jian Wang
Journal:  Front Mol Biosci       Date:  2022-01-13

3.  RIPK3 modulates sarcoma through immune checkpoint HAVCR2.

Authors:  Chen Qian; Deluo Wu; Jianwei Du
Journal:  Oncol Lett       Date:  2022-09-13       Impact factor: 3.111

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.